149 related articles for article (PubMed ID: 32090132)
1. Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes.
Zahran AM; El-Badawy O; Elsayh KI; Mohamed WMY; Riad KF; Abdel-Rahim MH; Rayan A
J Immunol Res; 2020; 2020():9736159. PubMed ID: 32090132
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
3. Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia.
Cavazzini F; Campioni D; Ferrari L; Buldini B; Bardi MA; Michielotto B; Lazzari MC; Ongari M; Dabusti M; Daghia G; Sofritti O; Basso G; Lanza F; Cuneo A
Cytometry B Clin Cytom; 2016 May; 90(3):247-56. PubMed ID: 26102234
[TBL] [Abstract][Full Text] [Related]
4. [Expression of CD146 in Adult and Children's Acute B Cell Lymphoblastic Leukemia and Its Significance].
Xie XQ; Wang WM; Gan SL; Chen SM; Zhang QT; Xie XS; Liu YF; Cheng YD; Liu YF; Xu XJ; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):30-34. PubMed ID: 28245371
[TBL] [Abstract][Full Text] [Related]
5. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
[TBL] [Abstract][Full Text] [Related]
6. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
7. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
8. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
Naeem S; Bukhari MH
J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
[TBL] [Abstract][Full Text] [Related]
10. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
11. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
13. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
[TBL] [Abstract][Full Text] [Related]
14. A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile.
Elshal MF; Khan SS; Raghavachari N; Takahashi Y; Barb J; Bailey JJ; Munson PJ; Solomon MA; Danner RL; McCoy JP
BMC Immunol; 2007 Nov; 8():29. PubMed ID: 17999761
[TBL] [Abstract][Full Text] [Related]
15. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
[TBL] [Abstract][Full Text] [Related]
16. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
20. PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy.
Zhang YH; Lu AD; Yang L; Li LD; Chen WM; Long LY; Zhang LP; Qin YZ
Leuk Res; 2017 Jan; 52():43-49. PubMed ID: 27875783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
